NEW YORK (GenomeWeb) – Cancer Genetics today announced it has received conditional licensure from the New York State Department of Health for its FISH-based HPV-Associated Cancer Test (FHACT) for cervical cancer.

The test, which received US approval as a laboratory-developed test under CLIA in late 2013, assesses genomic changes often found in cervical cancers and can identify women who are at higher risk for disease progression, the firm said in a statement. 

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

In Science this week: International Wheat Genome Sequencing Consortium publishes the bread wheat cultivar Chinese Spring reference genome, and more.

At his FDA Law Blog, Jeffrey Gibbs discusses FDA's technical assistance for the draft Diagnostic Accuracy and Innovation Act.

The New York Times reports that genetic testing has uncovered unfaithful penguins at a Utah aquarium.

Cancer researcher loses funding under new Wellcome Trust anti-bullying policies, the Guardian reports.